Clinical Trials Browser

Phase 2 × ridaforolimus × Thoracic × Clear all

NCT00818675 2015-01-21

A Study of Ridaforolimus in Non-Small Cell Lung Cancer (NSCLC) Patients With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutations (MK-8669-021 AM1)

Phase 2 Terminated

Carcinoma, Non-Small-Cell Lung